Clover (ASX:CLV) share price falls 10% on FY20 results

The Clover (ASX: CLV) share price has plummeted 10% in early morning trade following the release of its FY20 results. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clover Corporation Limited (ASX: CLV) share price has plummeted 10.33% in early morning trade following the release of its FY20 results. The Clover share price reached as low as $2.13, before pushing back to $2.17 at the time of writing. 

Let's take a look at Clover's results for the financial year.

How did Clover perform in FY2020?

Clover reported a decent FY20 result underpinned by new products delivering growth in new segments and countries.

For the full year ending 31 July, Clover announced a revenue increase of $88.3 million, up 15% over FY 2019.  This was driven by improved demand across all key regions, particularly in Europe.

Earnings before interest, tax, depreciation and amortisation (EBITDA) came in at $18.9 million, an increase of 35% from $14 million in the prior period.

Net profit after tax stood at $12.5 million, an increase of 23.6% compared to $10.1 million the year before.

Earnings per share also increased to 7.51 cents, compared to 6.12 cents.

Clover revealed an operating expense of $11.4 million from investment in research and development programs to deliver future growth. This was a jump from the $10.3 million spent in FY2019.

Inventory leapt to $31.9 million, up from $4.2 million.

Clover advised its balance sheet is strong with $9.2 million cash on hand and a net debt of just $5.4 million.

The infant formula company declared a final dividend of 2.5 cents per share to be paid to shareholders on 18 November.

COVID-19 impact

Clover said that its FY20 result had been positively impacted by COVID-19 with increased demand through Q3 and Q4. This was due to its customers supplying additional infant formula to retail channels depleted by pantry stocking.

The company did advise, however, that new customer development had been curtailed due to the imposed travel restrictions. This affected its ability to perform audits, and attend trade shows.

Demand in the United States from new business development had been constrained as the company focused on other activities. Clover resourced its overseas team to service new and existing customers.

FY 2021 outlook

Due to the uncertainty of COVID-19, the company did not provide a guidance for 1HFY21. However, Clover mentioned that the pantry stocking from consumers could support strong sales in the first half of the year.

In addition, the company will seek to target new customers in Europe to meet the new IF standards and establish online or third-party audits.

Clover will also look to restart new product development in the United States, and increase supply chain vertical integration.

About the Clover share price

The Clover share price has made a strong comeback of 63% since falling as low as $1.33 in March. For the calendar year to date, the Clover share price is down 17.49% and has also fallen 34.44% from its 52-week high.

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »